a website banner telling users to subscribe to it's newsletter

Ildong Pharmaceutical Partners with Hanlim Pharm to Promote OTC Eye Drops

Ildong Pharmaceutical Partners with Hanlim Pharm to Promote OTC Eye Drops

January 10, 2024

In a strategic move to enter the Over-the-Counter (OTC) market within the ophthalmology sector, Ildong Pharmaceutical has signed an eye drop co-promotion agreement with Hanlim Pharm. The collaboration marks a significant step for Ildong Pharmaceutical as it aims to expand its presence in the domestic pharmacy market.

The co-promotion will focus on three exclusive brands of over-the-counter eye drops – Nazorin, Numaren, and Eyefeel – all set to be distributed and sold exclusively by Ildong Pharmaceutical starting this month.

Nazorin Eye Drops: Containing pheniramine maleate-naphazoline HCI, Nazorin Eye Drops offer temporary relief from eye irritation and redness, providing consumers with an effective solution for ocular discomfort.

Numaren Eye Drops: Designed as an artificial tear for dry eyes and lack of tear production, Numaren Eye Drops, with its hypromellose-dextran formulation, is available in both single-dose and multi-dose packaging. The single-dose variant is preservative-free, catering to users even when wearing lenses.

Eyefeel Eye Drops: An innovative ophthalmic solution, Eyefeel Eye Drops consist of aminocaproic acid-neostigmine methylsulfate-naphazoline HCI-chlorpheniramine maleate. This formulation is specifically crafted to address eye inflammation, fatigue, and redness.

Kang Dae-seok, Head of CHC-CM Group at Ildong Pharmaceutical, expressed confidence in the collaboration, stating, "Based on our market research, we found that the number of consumers looking for ophthalmic solutions at pharmacies is steadily increasing due to the growing use of IT devices, including computers and smartphones. We will continue to promote the importance of eye health with our products."